Lewy Body Dementia Research in Latin America: A Scoping Review
View abstract on PubMed
Summary
This summary is machine-generated.Research on Lewy body dementia (LBD) in Latin America is scarce, with most studies being observational and lacking rigorous methodology. Addressing this requires increased awareness, capacity building, and international collaboration to improve LBD understanding in the region.
Area Of Science
- Neurology
- Neuroscience
- Public Health
Background
- Lewy body dementia (LBD) research in Latin America (LA) is significantly underrepresented compared to other dementia types.
- Existing research predominantly focuses on Alzheimer's Disease and Frontotemporal Dementia, neglecting LBD.
Purpose Of The Study
- To conduct a comprehensive review of existing evidence on Lewy body dementia (LBD) within Latin America.
- To identify challenges and regional characteristics contributing to the scarcity of LBD research.
Main Methods
- A scoping review was performed across major databases: PubMed, EMBASE, LILACS, and Web of Science.
- Included studies focused on participants diagnosed with Lewy body dementia (LBD).
Main Results
- Out of 1388 identified studies, 70 met the inclusion criteria for this review.
- The majority of studies (63) were cross-sectional, with limited longitudinal designs and only two non-randomized clinical trials.
- Research concentrated on clinical features, risk factors, and cognitive/non-motor symptoms, with Brazil contributing the most studies (52).
Conclusions
- Lewy body dementia (LBD) research in Latin America is characterized by underrepresentation and methodological limitations, predominantly cross-sectional designs.
- Significant challenges include weak study designs, heterogeneity, and a lack of rigorous clinical trials.
- Future efforts should focus on increasing awareness, enhancing research capacity, securing funding, and promoting international collaboration to advance LBD research in LA.